Evolent Health (EVH) Issues Earnings Results

Share on StockTwits

Evolent Health (NYSE:EVH) announced its quarterly earnings data on Tuesday. The technology company reported ($0.04) EPS for the quarter, beating the Zacks’ consensus estimate of ($0.11) by $0.07, Briefing.com reports. Evolent Health had a negative net margin of 9.84% and a negative return on equity of 1.82%. The company had revenue of $150.16 million for the quarter, compared to the consensus estimate of $142.94 million. During the same period in the prior year, the firm posted ($0.18) EPS. The company’s quarterly revenue was up 38.6% compared to the same quarter last year.

Shares of NYSE:EVH traded up $3.17 during trading hours on Wednesday, reaching $26.03. The stock had a trading volume of 2,892,214 shares, compared to its average volume of 889,023. Evolent Health has a 1 year low of $10.30 and a 1 year high of $29.05. The company has a current ratio of 2.59, a quick ratio of 2.59 and a debt-to-equity ratio of 0.12. The company has a market cap of $1.79 billion, a PE ratio of -37.19 and a beta of 1.50.

In related news, CEO Frank J. Williams sold 3,878 shares of the stock in a transaction on Monday, August 20th. The shares were sold at an average price of $24.00, for a total value of $93,072.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, COO Thomas Peterson III sold 70,000 shares of the stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $27.50, for a total transaction of $1,925,000.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 204,607 shares of company stock worth $5,240,751. Insiders own 4.82% of the company’s stock.

Several hedge funds and other institutional investors have recently bought and sold shares of EVH. NumerixS Investment Technologies Inc purchased a new position in shares of Evolent Health in the 2nd quarter valued at $105,000. LPL Financial LLC purchased a new position in shares of Evolent Health in the 1st quarter valued at $184,000. Xact Kapitalforvaltning AB purchased a new position in shares of Evolent Health in the 1st quarter valued at $190,000. Public Employees Retirement Association of Colorado grew its position in shares of Evolent Health by 106.3% in the 3rd quarter. Public Employees Retirement Association of Colorado now owns 6,904 shares of the technology company’s stock valued at $196,000 after buying an additional 3,557 shares during the last quarter. Finally, Paloma Partners Management Co purchased a new position in shares of Evolent Health in the 2nd quarter valued at $209,000.

A number of brokerages have commented on EVH. Wells Fargo & Co reissued an “outperform” rating and issued a $34.00 price objective (up from $26.00) on shares of Evolent Health in a research report on Wednesday. Piper Jaffray Companies reissued an “overweight” rating and issued a $34.00 price objective on shares of Evolent Health in a research report on Wednesday. ValuEngine downgraded shares of Evolent Health from a “strong-buy” rating to a “buy” rating in a research report on Thursday, November 1st. Leerink Swann set a $35.00 price objective on shares of Evolent Health and gave the company a “buy” rating in a research report on Friday, October 5th. Finally, Citigroup increased their price objective on shares of Evolent Health from $25.00 to $32.00 and gave the company a “buy” rating in a research report on Thursday, October 4th. One equities research analyst has rated the stock with a sell rating and thirteen have given a buy rating to the company. The stock has a consensus rating of “Buy” and an average target price of $31.73.

WARNING: This piece was first published by Macon Daily and is the property of of Macon Daily. If you are viewing this piece on another site, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this piece can be viewed at https://macondaily.com/2018/11/07/evolent-health-evh-issues-earnings-results.html.

About Evolent Health

Evolent Health, Inc, through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the United States. The company operates as a managed services firm that supports health systems and physician organizations in migration toward value-based care and population health management.

Featured Article: Reverse Stock Split

Earnings History for Evolent Health (NYSE:EVH)

Receive News & Ratings for Evolent Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evolent Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply